Search
for

    Sort by

    Research 571–600 of 1000+

    1. Referee report. For: Recent advances in treatment for Benign Prostatic Hyperplasia [version 1; referees: 2 approved] Faculty of 1000 Research Ltd · 2015
    2. Risks and side effects in the medical management of benign prostatic hyperplasia Prostate International · 2023 · 26 citations
    3. Recent advances in treatment for Benign Prostatic Hyperplasia F1000Research · 2015 · 12 citations
    4. Effect of a novel steroid (PM-9) on the inhibition of 5α-reductase present in Penicillium crustosum broths Steroids · 2003 · 22 citations
    5. Long-term use of 5α-reductase inhibitors and the risk of male breast cancer Cancer Causes & Control · 2014 · 28 citations
    6. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review The European Journal of Contraception & Reproductive Health Care · 2017 · 11 citations
    7. Experimental Assessment of 3-<i>meta</i>-Pyridine-1,2,4-Oxadiazole Deoxycholic Acid Derivative as a Prototype of 5-α-Reductase Inhibitors <i>in silico</i> and <i>in vivo</i> Models Bioorganičeskaâ himiâ · 2023
    8. When two plus two must not equal four British Journal of Urology · 2011
    9. Clinical risk factors associated with intraoperative floppy iris syndrome: a prospective study International Ophthalmology · 2018 · 22 citations
    10. Dual effects of 5α-reductase inhibitor dutasteride on androgenetic alopecia and acne vulgaris Dermatologica Sinica · 2019
    11. DIHYDROTESTOSTERONE AND THE PROSTATE: THE SCIENTIFIC RATIONALE FOR 5α-REDUCTASE INHIBITORS IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA 2004 · 235 citations
    12. ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer 2013 · 224 citations
    13. A Review on the Clinical Utility of PSA in Cancer Prostate Indian Journal of Surgical Oncology · 2012 · 154 citations
    14. Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted <sup>99m</sup>Tc-Radioimaging Agents Molecular Pharmaceutics · 2009 · 148 citations
    15. The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention 2011 · 147 citations
    16. Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer Communications biology · 2020 · 113 citations
    17. 5α‐Reductase Isozymes and Androgen Actions in the Prostate Annals of the New York Academy of Sciences · 2009 · 93 citations
    18. Activated Polyamine Catabolism Depletes Acetyl-CoA Pools and Suppresses Prostate Tumor Growth in TRAMP Mice Journal of Biological Chemistry · 2004 · 91 citations
    19. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial Lancet Oncology · 2006 · 89 citations
    20. Selenium and vitamin E supplements for prostate cancer: evidence or embellishment? Urology · 2002 · 76 citations
    21. The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men 2008 · 72 citations
    22. Prostate cancer prevention Cancer · 2007 · 71 citations
    23. Prostate Cancer Early Detection, Version 2.2015 Journal of the National Comprehensive Cancer Network · 2015 · 67 citations
    24. Androgen Receptors and Androgen-Dependent Initiation of Protein Synthesis in the Prostate Vitamins and hormones · 1976 · 59 citations
    25. Steroidogenesis inhibitors alter but do not eliminate androgen synthesis mechanisms during progression to castration-resistance in LNCaP prostate xenografts The Journal of Steroid Biochemistry and Molecular Biology · 2009 · 57 citations
    26. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications The Prostate · 1986 · 57 citations
    27. Matriptase activation and shedding with HAI-1 is induced by steroid sex hormones in human prostate cancer cells, but not in breast cancer cells American journal of physiology. Cell physiology · 2006 · 56 citations
    28. Liarozole—a novel treatment approach for advanced prostate cancer: results of a large randomized trial versus cyproterone acetate Urology · 1998 · 52 citations
    29. Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial British Journal of Cancer · 2009 · 49 citations
    30. 5-α-Reductase inhibitors for prostate cancer chemoprevention: an updated Cochrane systematic review BJUI · 2010 · 44 citations